Existence of functional M3-muscarinic receptors in the human heart

被引:32
作者
Willmy-Matthes, P
Leineweber, K
Wangemann, T
Silber, RE
Brodde, OE
机构
[1] Univ Essen Gesamthsch, Sch Med, Dept Pathophysiol, D-45147 Essen, Germany
[2] Univ Halle Wittenberg, Inst Pharmacol, D-06097 Halle Saale, Germany
[3] Univ Halle Wittenberg, Clin Cardiothorac Surg, D-06097 Halle Saale, Germany
[4] Univ Essen Gesamthsch, Sch Med, Dept Nephrol, D-45147 Essen, Germany
关键词
human right atrium; inositol phosphates; M-3-receptors; darifenacin; carbachol;
D O I
10.1007/s00210-003-0796-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It has been recently shown that, in adult rat ventricular cardiomyocytes, functional muscarinic receptors (M-receptors) of the M-3-subtype exist that mediate inositol phosphate (IP) formation. The aim of this study was to characterize the M-receptor subtype mediating IP formation in the human heart. For this purpose in [H-3]-myo-inositol labeled slices of human right atria, carbachol-induced [H-3]-IP formation and its inhibition by several M-receptor antagonists was assessed. Carbachol (0.1 muM-100 muM) increased [H-3]-IP formation; maximal increase at 100 muM was 93+/-16% above basal (n=20); the pEC(50)-value for carbachol was 5.56. Atropine (1 muM) completely suppressed 100 muM carbachol-induced [H-3]-IP formation. Among the M-receptor subtype "selective" antagonists himbacine (1 muM) and pirenzepine (1 muM) only marginally affected carbachol-induced [H-3]-IP formation whereas the M-3-receptor antagonist darifenacin (1 nM-1 muM) concentration-dependently inhibited carbachol-induced [H-3]-IP formation with a pK(i)-value of 8.49. We conclude that in human right atrium there exist functional M-3-receptors that couple to IP formation.
引用
收藏
页码:316 / 319
页数:4
相关论文
共 14 条
  • [1] BRISTOW MR, 1988, J PHARMACOL EXP THER, V247, P1039
  • [2] Brodde OE, 1999, PHARMACOL REV, V51, P651
  • [3] SIGNAL-TRANSDUCTION MECHANISMS CONTROLLING CARDIAC CONTRACTILITY AND THEIR ALTERATIONS IN CHRONIC HEART-FAILURE
    BRODDE, OE
    MICHEL, MC
    ZERKOWSKI, HR
    [J]. CARDIOVASCULAR RESEARCH, 1995, 30 (04) : 570 - 584
  • [4] Caulfield MP, 1998, PHARMACOL REV, V50, P279
  • [5] Muscarinic receptors in the mammalian heart
    Dhein, S
    Van Koppen, CJ
    Brodde, OE
    [J]. PHARMACOLOGICAL RESEARCH, 2001, 44 (03) : 161 - 182
  • [6] Muscarinic M3 receptor subtype gene expression in the human heart
    Hellgren, I
    Mustafa, A
    Riazi, M
    Suliman, I
    Sylvén, C
    Adem, A
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) : 175 - 180
  • [7] Gender comparison of muscarinic receptor expression and function in rat and human urinary bladder:: differential regulation of M2 and M3 receptors?
    Kories, C
    Czyborra, C
    Fetscher, C
    Schneider, T
    Krege, S
    Michel, MC
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (05) : 524 - 531
  • [8] Acetylcholine release in human heart atrium - Influence of muscarinic autoreceptors, diabetes, and age
    Oberhauser, V
    Schwertfeger, E
    Rutz, T
    Beyersdorf, F
    Rump, LC
    [J]. CIRCULATION, 2001, 103 (12) : 1638 - 1643
  • [9] Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats
    Pönicke, K
    Heinroth-Hoffmann, I
    Brodde, OE
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (01) : 156 - 160
  • [10] Skomedal T, 1997, J PHARMACOL EXP THER, V280, P721